Kizzmekia S Corbett-Helaire, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antibodies, Neutralizing | 31 | 2024 | 1957 | 2.830 |
Why?
|
Antibodies, Viral | 34 | 2024 | 3151 | 2.670 |
Why?
|
Viral Vaccines | 7 | 2023 | 631 | 1.350 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 3 | 2022 | 158 | 0.830 |
Why?
|
Laboratory Personnel | 1 | 2020 | 19 | 0.770 |
Why?
|
Primates | 3 | 2024 | 544 | 0.750 |
Why?
|
Moral Obligations | 1 | 2020 | 98 | 0.710 |
Why?
|
Ebolavirus | 1 | 2022 | 263 | 0.710 |
Why?
|
Vaccines, Virus-Like Particle | 2 | 2019 | 40 | 0.700 |
Why?
|
Pandemics | 9 | 2022 | 8274 | 0.690 |
Why?
|
Coronavirus Infections | 11 | 2021 | 3143 | 0.690 |
Why?
|
Dengue Virus | 3 | 2018 | 205 | 0.680 |
Why?
|
Image Cytometry | 1 | 2018 | 54 | 0.660 |
Why?
|
Health Planning | 1 | 2020 | 237 | 0.660 |
Why?
|
Influenza Vaccines | 3 | 2022 | 740 | 0.630 |
Why?
|
Vaccines | 2 | 2023 | 802 | 0.620 |
Why?
|
Dengue | 3 | 2018 | 259 | 0.620 |
Why?
|
Macaca mulatta | 8 | 2023 | 2384 | 0.620 |
Why?
|
Pneumonia, Viral | 7 | 2020 | 3248 | 0.600 |
Why?
|
Antigens, Viral | 2 | 2019 | 1033 | 0.590 |
Why?
|
Mentors | 1 | 2020 | 632 | 0.530 |
Why?
|
Career Choice | 1 | 2021 | 742 | 0.520 |
Why?
|
Research | 1 | 2021 | 2001 | 0.440 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 953 | 0.430 |
Why?
|
Immunization, Secondary | 4 | 2021 | 336 | 0.430 |
Why?
|
Cross Reactions | 8 | 2021 | 840 | 0.430 |
Why?
|
Mesocricetus | 2 | 2021 | 250 | 0.400 |
Why?
|
Immunization, Passive | 3 | 2021 | 625 | 0.370 |
Why?
|
Virus Replication | 4 | 2021 | 2529 | 0.360 |
Why?
|
Bottle Feeding | 2 | 2000 | 68 | 0.350 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2021 | 765 | 0.340 |
Why?
|
Vaccination | 8 | 2024 | 3232 | 0.330 |
Why?
|
RNA, Viral | 3 | 2021 | 2907 | 0.320 |
Why?
|
Epitopes | 4 | 2023 | 2558 | 0.310 |
Why?
|
Nose | 2 | 2021 | 499 | 0.300 |
Why?
|
Neutralization Tests | 4 | 2021 | 757 | 0.300 |
Why?
|
Receptors, Virus | 6 | 2020 | 648 | 0.290 |
Why?
|
Coronavirus | 2 | 2020 | 158 | 0.270 |
Why?
|
Th1 Cells | 2 | 2021 | 1055 | 0.270 |
Why?
|
Animals | 28 | 2024 | 168368 | 0.260 |
Why?
|
B-Lymphocytes | 1 | 2019 | 4663 | 0.260 |
Why?
|
Vaccines, Synthetic | 3 | 2021 | 631 | 0.240 |
Why?
|
Antibody Affinity | 2 | 2021 | 254 | 0.240 |
Why?
|
Vero Cells | 2 | 2021 | 484 | 0.220 |
Why?
|
Orthomyxoviridae Infections | 2 | 2022 | 252 | 0.220 |
Why?
|
Coronavirus OC43, Human | 1 | 2021 | 18 | 0.210 |
Why?
|
Respiratory Syncytial Viruses | 3 | 2015 | 164 | 0.210 |
Why?
|
Viral Load | 2 | 2021 | 3299 | 0.210 |
Why?
|
Protein Multimerization | 4 | 2020 | 970 | 0.200 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2022 | 112 | 0.200 |
Why?
|
Antibody Formation | 2 | 2023 | 1398 | 0.200 |
Why?
|
Sri Lanka | 3 | 2018 | 92 | 0.200 |
Why?
|
Breast Feeding | 2 | 2000 | 1334 | 0.190 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2020 | 58 | 0.190 |
Why?
|
Maternal-Child Nursing | 1 | 2000 | 3 | 0.190 |
Why?
|
Immunization Schedule | 1 | 2021 | 219 | 0.180 |
Why?
|
Cell Line | 5 | 2021 | 15987 | 0.180 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2020 | 370 | 0.180 |
Why?
|
North Carolina | 1 | 2020 | 310 | 0.180 |
Why?
|
Seroepidemiologic Studies | 3 | 2020 | 401 | 0.180 |
Why?
|
RNA, Messenger | 5 | 2022 | 13002 | 0.180 |
Why?
|
Ferritins | 2 | 2020 | 589 | 0.180 |
Why?
|
Immunity, Mucosal | 2 | 2021 | 491 | 0.180 |
Why?
|
Lung | 4 | 2021 | 9782 | 0.170 |
Why?
|
Fathers | 1 | 2021 | 357 | 0.170 |
Why?
|
Biotechnology | 1 | 2021 | 277 | 0.170 |
Why?
|
Immunoglobulin G | 5 | 2021 | 4522 | 0.170 |
Why?
|
Molecular Probes | 1 | 2020 | 318 | 0.160 |
Why?
|
Nanoparticles | 2 | 2020 | 1906 | 0.160 |
Why?
|
Nasal Mucosa | 1 | 2021 | 372 | 0.160 |
Why?
|
Infant Food | 1 | 1999 | 140 | 0.160 |
Why?
|
Quarantine | 1 | 2020 | 169 | 0.160 |
Why?
|
History, 21st Century | 2 | 2021 | 1534 | 0.160 |
Why?
|
Mice | 12 | 2023 | 81002 | 0.150 |
Why?
|
Awards and Prizes | 1 | 2021 | 375 | 0.150 |
Why?
|
Toll-Like Receptor 4 | 1 | 2020 | 560 | 0.150 |
Why?
|
Protein Stability | 1 | 2018 | 554 | 0.140 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2020 | 812 | 0.140 |
Why?
|
Respiratory Syncytial Virus Infections | 2 | 2011 | 323 | 0.140 |
Why?
|
Research Personnel | 1 | 2021 | 571 | 0.140 |
Why?
|
Cryoelectron Microscopy | 4 | 2020 | 567 | 0.130 |
Why?
|
Protein Structure, Secondary | 1 | 2018 | 1245 | 0.130 |
Why?
|
Biomedical Research | 2 | 2021 | 3301 | 0.130 |
Why?
|
Vulnerable Populations | 1 | 2020 | 685 | 0.130 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 744 | 0.130 |
Why?
|
Antigens | 1 | 2020 | 1462 | 0.130 |
Why?
|
Immunologic Memory | 1 | 2021 | 1348 | 0.120 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2000 | 3908 | 0.120 |
Why?
|
Virus Diseases | 1 | 2020 | 710 | 0.120 |
Why?
|
Drug Carriers | 1 | 2019 | 693 | 0.120 |
Why?
|
Humans | 37 | 2024 | 739398 | 0.120 |
Why?
|
Minority Groups | 1 | 2021 | 1197 | 0.120 |
Why?
|
Protein Binding | 4 | 2020 | 9375 | 0.120 |
Why?
|
Female | 17 | 2023 | 378853 | 0.120 |
Why?
|
Peptidyl-Dipeptidase A | 3 | 2020 | 364 | 0.120 |
Why?
|
Polysaccharides | 1 | 2020 | 1050 | 0.110 |
Why?
|
Disease Outbreaks | 1 | 2022 | 1779 | 0.110 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1476 | 0.110 |
Why?
|
Antibodies, Monoclonal | 4 | 2022 | 9259 | 0.100 |
Why?
|
Influenza, Human | 1 | 2022 | 1476 | 0.100 |
Why?
|
Respiratory Syncytial Virus Vaccines | 1 | 2010 | 32 | 0.090 |
Why?
|
Plasmids | 1 | 2015 | 2307 | 0.090 |
Why?
|
Male | 10 | 2023 | 349022 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2021 | 2971 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4374 | 0.080 |
Why?
|
Papillomavirus Vaccines | 1 | 2015 | 490 | 0.080 |
Why?
|
T-Lymphocytes | 3 | 2020 | 10142 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2020 | 4424 | 0.080 |
Why?
|
Poverty | 1 | 2000 | 2626 | 0.080 |
Why?
|
Mothers | 1 | 1999 | 2143 | 0.080 |
Why?
|
Virion | 1 | 2010 | 435 | 0.080 |
Why?
|
Antibody Specificity | 2 | 2020 | 1096 | 0.080 |
Why?
|
Parents | 1 | 2021 | 3368 | 0.080 |
Why?
|
Immune Evasion | 2 | 2021 | 358 | 0.080 |
Why?
|
Peptide Hydrolases | 2 | 2021 | 627 | 0.070 |
Why?
|
Mucous Membrane | 1 | 2010 | 667 | 0.070 |
Why?
|
Mice, Inbred BALB C | 3 | 2021 | 6397 | 0.070 |
Why?
|
Feeding Behavior | 1 | 1999 | 3180 | 0.070 |
Why?
|
Glycosylation | 2 | 2020 | 1125 | 0.070 |
Why?
|
Infant | 5 | 2023 | 34923 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18003 | 0.060 |
Why?
|
Models, Molecular | 3 | 2020 | 5460 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 3863 | 0.060 |
Why?
|
Mutation | 4 | 2021 | 29658 | 0.060 |
Why?
|
Virus Internalization | 2 | 2018 | 499 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14740 | 0.060 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1585 | 0.060 |
Why?
|
Crystallography, X-Ray | 2 | 2018 | 2015 | 0.060 |
Why?
|
Recurrence | 1 | 2014 | 8307 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2015 | 2012 | 0.050 |
Why?
|
Hemagglutinins | 1 | 2022 | 117 | 0.050 |
Why?
|
Ferrets | 1 | 2022 | 194 | 0.050 |
Why?
|
Viral Matrix Proteins | 2 | 2015 | 185 | 0.050 |
Why?
|
Common Cold | 1 | 2021 | 61 | 0.050 |
Why?
|
Skin | 1 | 2015 | 4324 | 0.050 |
Why?
|
Antigen-Antibody Reactions | 1 | 2021 | 364 | 0.050 |
Why?
|
Camelids, New World | 1 | 2020 | 20 | 0.050 |
Why?
|
Epitope Mapping | 1 | 2021 | 312 | 0.050 |
Why?
|
Protein Conformation | 2 | 2020 | 4012 | 0.050 |
Why?
|
Macaca | 1 | 2022 | 443 | 0.050 |
Why?
|
Biotinylation | 1 | 2020 | 178 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2018 | 19811 | 0.050 |
Why?
|
Binding Sites, Antibody | 1 | 2020 | 349 | 0.050 |
Why?
|
Plasma Cells | 1 | 2024 | 591 | 0.050 |
Why?
|
South Carolina | 1 | 2000 | 99 | 0.050 |
Why?
|
Asparagine | 1 | 2020 | 123 | 0.050 |
Why?
|
Dendritic Cells | 1 | 2011 | 2728 | 0.040 |
Why?
|
Adult | 7 | 2021 | 213394 | 0.040 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2021 | 482 | 0.040 |
Why?
|
Nursing Methodology Research | 1 | 1999 | 67 | 0.040 |
Why?
|
Child, Preschool | 3 | 2020 | 40802 | 0.040 |
Why?
|
Anthropology, Cultural | 1 | 1999 | 96 | 0.040 |
Why?
|
United States | 3 | 2021 | 69573 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2024 | 995 | 0.040 |
Why?
|
Viral Tropism | 1 | 2018 | 101 | 0.040 |
Why?
|
Coronaviridae | 1 | 2017 | 13 | 0.040 |
Why?
|
Immunization | 1 | 2022 | 1255 | 0.040 |
Why?
|
Trypsin | 1 | 2018 | 507 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2021 | 780 | 0.040 |
Why?
|
Surface Properties | 1 | 2020 | 1181 | 0.040 |
Why?
|
Cricetinae | 1 | 2021 | 2468 | 0.040 |
Why?
|
Helicobacter pylori | 1 | 2020 | 379 | 0.040 |
Why?
|
Protease Inhibitors | 1 | 2021 | 792 | 0.040 |
Why?
|
Multienzyme Complexes | 1 | 2020 | 687 | 0.040 |
Why?
|
Proline | 1 | 2018 | 454 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2021 | 2833 | 0.040 |
Why?
|
Immunoglobulins | 1 | 2020 | 881 | 0.040 |
Why?
|
Mother-Child Relations | 1 | 2000 | 479 | 0.030 |
Why?
|
Drug Design | 1 | 2021 | 1088 | 0.030 |
Why?
|
World Health Organization | 1 | 2021 | 1321 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2021 | 2732 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2021 | 2881 | 0.030 |
Why?
|
Viral Fusion Proteins | 1 | 2015 | 95 | 0.030 |
Why?
|
Genome, Viral | 1 | 2018 | 668 | 0.030 |
Why?
|
Protein Structure, Quaternary | 1 | 2016 | 437 | 0.030 |
Why?
|
Models, Psychological | 1 | 1999 | 809 | 0.030 |
Why?
|
Young Adult | 4 | 2021 | 56255 | 0.030 |
Why?
|
Membrane Fusion | 1 | 2016 | 271 | 0.030 |
Why?
|
Microinjections | 1 | 2015 | 326 | 0.030 |
Why?
|
Travel | 1 | 2020 | 787 | 0.030 |
Why?
|
Molecular Typing | 1 | 2014 | 108 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2018 | 19220 | 0.030 |
Why?
|
Child | 3 | 2020 | 77033 | 0.030 |
Why?
|
Prospective Studies | 2 | 2014 | 53037 | 0.030 |
Why?
|
Human papillomavirus 16 | 1 | 2015 | 261 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2021 | 1834 | 0.030 |
Why?
|
Luciferases | 1 | 2015 | 734 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2017 | 595 | 0.030 |
Why?
|
Administration, Cutaneous | 1 | 2015 | 708 | 0.030 |
Why?
|
Protein Subunits | 1 | 2016 | 964 | 0.030 |
Why?
|
Needles | 1 | 2015 | 448 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2017 | 3146 | 0.030 |
Why?
|
Immune System Phenomena | 1 | 2011 | 16 | 0.020 |
Why?
|
Transgenes | 1 | 2015 | 1010 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2011 | 68 | 0.020 |
Why?
|
Administration, Mucosal | 1 | 2010 | 7 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2015 | 1549 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2020 | 6610 | 0.020 |
Why?
|
Administration, Intravaginal | 1 | 2010 | 147 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2020 | 25470 | 0.020 |
Why?
|
Binding Sites | 1 | 2018 | 6113 | 0.020 |
Why?
|
Bacteria | 1 | 2020 | 2106 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4174 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6722 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 6174 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2016 | 3848 | 0.020 |
Why?
|
Vaccines, DNA | 1 | 2010 | 299 | 0.020 |
Why?
|
Adolescent | 3 | 2021 | 85405 | 0.020 |
Why?
|
DNA, Viral | 1 | 2015 | 2223 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10945 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11347 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2010 | 1837 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2020 | 3866 | 0.020 |
Why?
|
Middle Aged | 4 | 2021 | 212863 | 0.020 |
Why?
|
Immunoglobulin A | 1 | 2010 | 989 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2011 | 1858 | 0.020 |
Why?
|
Urban Population | 1 | 2014 | 2014 | 0.020 |
Why?
|
Epithelium | 1 | 2010 | 1684 | 0.020 |
Why?
|
Vagina | 1 | 2010 | 822 | 0.020 |
Why?
|
Aged | 3 | 2021 | 162698 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15153 | 0.010 |
Why?
|
Viral Proteins | 1 | 2010 | 1900 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 8977 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7788 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40050 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 24714 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2010 | 5522 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15511 | 0.010 |
Why?
|
Cytokines | 1 | 2011 | 7298 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 20913 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2011 | 11460 | 0.010 |
Why?
|